• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

CMC

Becraft
Favicon Fierce Biotech

Strand Tx CEO Jake Becraft weighs in on FDA's IND reform, China

The Strand Therapeutics CEO and BIO board director warned that the U.S. must modernize its regulatory framework for early-stage clinical trials.
Angus Liu May 4, 2026 12:00pm
whale jumping out of water

FDA delays decision on Orca Bio’s cell therapy for blood cancers

Apr 1, 2026 8:00am
Biogen

Biogen undeterred after FDA snub for high-dose Spinraza in SMA

Sep 24, 2025 9:51am
Martin Makary FDA Senate HELP confirmation

FDA debuts new program to ease US manufacturing plant setup

Aug 7, 2025 3:16pm
CRL RTF rejection

Savara's lung disease asset hit with FDA refuse-to-file letter

May 27, 2025 10:35am
diagram showing how SkinTE is made

Manufacturing issues force PolarityTE to halt skin repair IND

Aug 24, 2021 11:06am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings